On Feb 11, 2022 Cheplapharm Arzneimittel closed a Debt Financing round and raised €1,480,000,000 from investors, featuring lead investors . About the company: Cheplapharm Arzneimittel […]
Seed Round – Mindstate Design Labs
On Feb 10, 2022 Mindstate Design Labs closed a Seed round and raised $11,500,000 from Apoorva Mehta, Day One Ventures, Fred Ehrsam, Initialized Capital, K50 […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Seed Round – Mindstate Design Labs
On Feb 10, 2022 Mindstate Design Labs closed a Seed round and raised $11,500,000 from Apoorva Mehta, Day One Ventures, Fred Ehrsam, Initialized Capital, K50 […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Corporate Round – Vensica Medical
On Feb 7, 2022 Vensica Medical closed a Corporate Round round and raised $3,000,000 from Merz Therapeutics, featuring lead investors Merz Therapeutics. About the company: […]
Rewrite Therapeutics acquired by Intellia Therapeutics
Feb 3, 2022 Intellia Therapeutics has entered into an agreement to acquire Rewrite Therapeutics . Intellia Therapeutics based at Cambridge, Massachusetts, United States. ” Health […]
Series C – Dewpoint Therapeutics
On Feb 3, 2022 Dewpoint Therapeutics closed a Series C round and raised $150,000,000 from 3E Bioventures, ARCH Venture Partners, EcoR1 Capital, General Catalyst, Leaps […]
